Scholar Rock Holding Corporation
SRRK·Stocks·Biotechnology·United States·Nasdaq·USD
Price
$42.51
Today
-9.2%
YTD
+6.4%
About
Scholar Rock Holding Corporation, a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, develops novel medicines to address serious diseases triggered by protein growth factors. Scholar Rock Holding Corporation was founded in 2012 and operates locally within the United States. The SRRK ticker identifies the company on the NASDAQ GS. Manage news and updates on the SRRK stock index with eToro.
Price chart
Closing price history for SRRK (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-13.56
P/S (TTM)0.00
P/B (TTM)22.43
Market cap$5.70B
Cap tierMid-cap
Industry avg P/E-2.01
Profitability
Gross marginUnknown
EBIT margin0.00%
Net marginUnknown
ROE-167.77%
ROA-94.63%
Earnings & Revenue
Revenue (TTM)$0.00
Revenue growth (1Y)-100.0%
EPS (TTM)-$3.45
Free cash flow$-297.01M
Total debt$203.83M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.22
Employees289
Next earnings12 Nov '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.